STOCK TITAN

abrdn Healthcare Opportunities Fund - THQ STOCK NEWS

Welcome to our dedicated news page for abrdn Healthcare Opportunities Fund (Ticker: THQ), a resource for investors and traders seeking the latest updates and insights on abrdn Healthcare Opportunities Fund.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect abrdn Healthcare Opportunities Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of abrdn Healthcare Opportunities Fund's position in the market.

Rhea-AI Summary
abrdn U.S. Closed-End Funds (ASGI) announced distributions to shareholders on February 29, 2024. The Funds paid $0.1500 per share for abrdn Global Infrastructure Income Fund (ASGI), $0.1800 for abrdn Healthcare Opportunities Fund (THQ), and $0.1167 for abrdn World Healthcare Fund (THW). The distributions aim to provide stable income from current income, capital gains, and paid-in capital. The estimated sources of distributions include net investment income, short-term and long-term capital gains, and return of capital. Shareholders are cautioned that a return of capital does not reflect investment performance. The Funds' total return performance and distribution rates are also provided for investor reference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
-
Rhea-AI Summary
abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) have announced an increase in distribution rates approved by their respective Boards of Trustees. HQH and HQL will see a 25% increase from 8% to 10% in their managed distribution policy, while THQ will experience a 60% increase in its stable distribution policy. The distributions will be made from net investment income, net realized capital gains, and return of capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
abrdn U.S. Closed-End Funds (ASGI) announced distributions on November 30, 2023. ASGI distributed $0.1200 per share, THQ distributed $0.1125, and THW distributed $0.1167. The funds adopted a distribution policy for stable distribution out of current income, supplemented by realized capital gains and paid-in capital. The estimated sources of the distributions and the Funds' total return performance are detailed in the PR.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
none
Rhea-AI Summary
abrdn Healthcare Opportunities Fund, formerly known as Tekla Healthcare Opportunities Fund, paid a monthly distribution of $0.1125 per share on October 31, 2023. The distribution is derived from a return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains, indicating a potential return of capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none
-
Rhea-AI Summary
Tekla Healthcare Opportunities Fund declares monthly cash distribution
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
Rhea-AI Summary
Tekla Healthcare Opportunities Fund declares monthly cash distribution of $0.1125 per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
Rhea-AI Summary
Tekla Healthcare Opportunities Fund (NYSE: THQ) declares a monthly cash distribution of $0.1125 per share, with a record date of August 21, 2023, and a payable date of August 31, 2023. The Fund will trade ex-distribution on August 18, 2023. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan (“DRIP”) will have cash distributions automatically reinvested in shares. Tekla Healthcare Opportunities Fund is a closed-end fund investing in healthcare companies, with Tekla Capital Management LLC as the Investment Adviser. Shares can be purchased on the New York Stock Exchange through any securities broker.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Summary
Tekla Healthcare Opportunities Fund (THQ) has declared a monthly cash distribution of $0.1125 per share. The record date for the distribution is July 20, 2023, and the payable date is July 31, 2023. Only participants in the Fund's Dividend Reinvestment and Stock Purchase Plan will have cash distributions automatically reinvested in shares.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
abrdn Healthcare Opportunities Fund

NYSE:THQ

THQ Rankings

THQ Stock Data

781.22M
0%
20.76%
0.04%
Asset Management
Financial Services
Link
US
Boston

About THQ

tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form